Astellas Pharma Korea, Inc.

NCT03118713

Phase 4Terminated201733 people18 Apr 2017clinicaltrials.gov

NCT03076112

CollaboratorPhase 3Completed2017170 people9 Mar 2017clinicaltrials.gov

NCT02532634

CollaboratorPhase 4Completed2015292 people26 Aug 2015clinicaltrials.gov